These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3674900)

  • 1. [Clinical effects of bestrabucil (KM2210) in bladder cancer].
    Nasu Y; Saegusa M; Ochi J; Hara M; Akagi T; Obama T; Yoshimoto J; Matsumura Y; Ohmori H; Tsushima T
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3155-6. PubMed ID: 3674900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results in recurrent breast cancer with the use of Bestrabucil (KM2210)].
    Ueda T; Sakai K; Morimoto K; Nakatani S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3285-9. PubMed ID: 3688892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new anti-cancer agent, bestrabucil (KM 2210): I. Concentration in the serum and tissue in urogenital tumors].
    Nasu Y; Saegusa M; Hara M; Ochi J; Akagi T; Obama T; Tsushima T; Yoshimoto J; Ozaki Y; Matsumura Y
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1116-21. PubMed ID: 3566306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early phase II trial of bestrabucil in hematological malignancies].
    Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase I study of bestrabucil (KM 2210)].
    Kamei H; Takenaka K; Goto T; Suga S; Fugiwara A; Nakao I; Agatsuma T; Fujita K; Isurugi K; Kubota T
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2208-15. PubMed ID: 3755019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bestrabacil: a possible target-oriented anticancer agent].
    Ohsawa N; Yamazaki Z; Wagatsuma T; Isurugi K
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2115-24. PubMed ID: 6548354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].
    Nishikawa M; Uemura Y; Matsuoka N; Ohno T; Katayama N; Tomeoku M; Kobayashi T; Kita K; Tanaka H; Minami N
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2155-9. PubMed ID: 3521494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity and pharmacokinetics of estra-1,3,5 (10)-triene-3,17 beta-diol, 3-benzoate, 17-((4-(4-bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy) acetate) (Bestrabucil) in human tumor xenografts serially transplanted into nude mice.
    Kubota T; Kawamura E; Suzuki T; Yamada T; Toyoda H; Miyagawa T; Kurokawa T
    Jpn J Clin Oncol; 1986 Dec; 16(4):357-64. PubMed ID: 3795532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
    Naito K; Kubo K; Akao Y; Hiraiwa A; Naoe T; Yamada K
    Gan No Rinsho; 1986 Sep; 32(11):1443-50. PubMed ID: 2877106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences in tumor-oriented anti-cancer drugs].
    Ohsawa N
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):313-7. PubMed ID: 2841390
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of adult T cell leukemia treated with a new chemotherapeutic agent, KM2210].
    Ogawa T; Naito K; Yamada K
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):188-91. PubMed ID: 2879513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of recurrent breast carcinoma achieving CR (complete response) with KM2210].
    Kubota T; Yamada Y; Kawamura E; Toyoda H; Miyagawa T; Kurokawa T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2556-9. PubMed ID: 3619463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of carcinoma in the lower abdomen treated successfully with oral administration of bestrabucil].
    Tsujitani S; Baba H; Korenaga D; Haraguchi M; Hiramoto Y; Okamura T; Sugimachi K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2960-3. PubMed ID: 3662547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice.
    Kubota T; Ishibiki K; Abe O; Kosano H; Ohsawa N; Hoffman RM
    Anticancer Res; 1993; 13(4):935-40. PubMed ID: 8352562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intra-arterial chemotherapy with a new lipophilic anticancer agent, estradiol-chlorambucil (KM2210), dissolved in lipiodol on experimental liver tumor in rats.
    Egawa H; Maki A; Mori K; Yamamoto Y; Mitsuhashi S; Bannai K; Asano K; Ozawa K
    J Surg Oncol; 1990 Jun; 44(2):109-14. PubMed ID: 2162452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
    Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K
    Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
    Isurugi K
    Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bestrabucil-induced complete remission in a case of follicular lymphoma, medium-sized cell type, stage IV (leukemic)].
    Hirano M; Shirakawa S
    Gan No Rinsho; 1986 Sep; 32(11):1491-4. PubMed ID: 3534347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor-oriented anti-cancer agent with estrogen as a carrier].
    Ohsawa N; Yamazaki Z
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1065-71. PubMed ID: 3291767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of breast carcinoma with lung metastasis].
    Okayasu T; Masuda T; Kawabata M; Imai T; Hashimoto M; Inoue K; Tanabe T
    Gan No Rinsho; 1987 Jun; 33(6):720-2. PubMed ID: 3599480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.